Innovation and inclusion have become the cornerstone of Emory University’s strategic mission and particularly relevant during this unique time in higher education. A key part of this strategy is the promotion of connectivity through cross-disciplinary partnerships and the creation of diverse programs that cultivate success for everyone.
John and Rosemary Brown recognize that development in medicine and business today often requires similar efforts. Therefore, they have pledged to establish the John and Rosemary Brown Family Innovation to Market Fund within Emory School of Medicine as well as the Rosemary and John Brown Family Scholars Program within Emory’s Goizueta Business School.
“At Emory, we believe in re-envisioning the future and never being satisfied with what has been done before. We’re fueled by curiosity and know there’s more than one right answer to every problem,” says Vikas P. Sukhatme, MD, ScD, dean of Emory School of Medicine. “That’s why we are honored and grateful for the John and Rosemary Brown Family Innovation to Market Fund, which will allow us to continue bolstering interdisciplinary interactions and changing the way we think of medicine.”
“Goizueta is proud to launch this exciting initiative to increase representation of women in business,” says Karen Sedatole, interim John H. Harland Dean of Emory Goizueta Business School. “Women and minorities often are underrepresented in graduate business programs. This imbalance negatively affects students, business schools, and the larger business community. This generous endowment allows Goizueta to execute its bold vision to meet tomorrow’s challenges and reimagine what business education could and should be.”
Designed to provide focused philanthropy to advance human health innovation and foster a stronger representation of women in leadership roles, the generous $10 million gift allows Emory to continue investing in the advancement of its diverse communities.
John and Rosemary Brown Family Innovation to Market Fund
The John and Rosemary Brown Family Innovation to Market Fund will establish a fund to advance technologies through a three-pronged approach: provide foundational information for medical technology development, de-risking grant funding driven by heavy market and technical diligence, and nondilutive funding to prepare market-ready projects through industry expertise and ecosystem connectivity.
Since 1997, Emory School of Medicine and Georgia Tech have jointly run one of the top biomedical engineering programs in the world, the Wallace H. Coulter Department of Biomedical Engineering. Biolocity, a philanthropic program in the department, accelerates the commercialization of early-stage medical technologies with intellectual property held at Emory and/or Georgia Tech. Its resources and funding are available to all faculty members across both campuses. One of the primary goals of the John and Rosemary Brown Family Innovation to Market Fund includes expanding project funding opportunities through Biolocity.
“Rosemary and I are excited to see the opportunity for the disciplines of engineering and medicine to collaborate with a common goal. This focus will accelerate innovation that allows clinical needs to move forward more quickly to license, start-up and commercialization,” says John Brown.
Learn more about the John and Rosemary Brown Family Innovation to Market Fund.
